Mebendazole: A candidate FDA approved drug for repurposing in leukaemia

Kyle B. Matchett, Ivan V. Grishagin, Laura M. Kettyle, Gerald Gavory, Timothy Harrison, Ken Mills, Alexander Thompson

Research output: Contribution to conferenceAbstract

Original languageEnglish
Pages121-122
Number of pages1
Publication statusPublished - 01 Apr 2016
EventXXXVI World Congress International Society of Haematology - Glasgow, United Kingdom
Duration: 18 Apr 201621 Apr 2016

Conference

ConferenceXXXVI World Congress International Society of Haematology
CountryUnited Kingdom
CityGlasgow
Period18/04/201621/04/2016

Cite this

Matchett, K. B., Grishagin, I. V., Kettyle, L. M., Gavory, G., Harrison, T., Mills, K., & Thompson, A. (2016). Mebendazole: A candidate FDA approved drug for repurposing in leukaemia. 121-122. Abstract from XXXVI World Congress International Society of Haematology, Glasgow, United Kingdom.